Role of Total Body Irradiation in Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: Implications for Clinical Practice (SOHO 2026) - Sep 1, 2026 - Abstract #CT-1186; Location: LEVEL 3, HALL B3; "Twenty-one patients received posttransplant TKI maintenance: dasatinib (n = 11), imatinib (n = 8), or ponatinib (n = 2). This study included 25 patients. Median age was 46 years (range, 33–58 years); 12 were male and 13 were female. Pretransplant status was CR1 in 88% of patients, CR2 in 8%, and ≥CR3 in 4%."
Clinical • Acute Lymphocytic Leukemia • Hematological Malignancies • Leukemia • Oncology
|
|
Hegta Figueiroa MD; Victor Rocha MD; André Americo MD; Fabio Kerbauy MD; Phillip Scheinberg PhD
|